IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow

Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive ...
Business Wire

IGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63 Receives Award

POTOMAC, Maryland--(BUSINESS WIRE)--IGC Pharma, Inc (NYSE American: IGC) ("IGC" or the "Company"), today announced that its Advisor, Professor T. Govindaraju the inventor of the investigational ...

IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company

Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts owed, including more than ...
Collinsville Daily News on MSN

IGC Pharma (NYSE: IGC) CEO discusses AI, Alzheimer's drug development and key 2026 catalysts on The Street podcast

Investors following the rapidly growing Alzheimer's disease, Artificial Intelligence (AI), and biotechnology sectors now have ...

IGC Pharma Executives Convert Debt Into Equity Shares

IGC Pharma ( (IGC)) has issued an update. On June 30, 2026, IGC Pharma’s CEO Ram Mukunda and Vice President and Principal Financial Officer Claudia Grimaldi converted a combined $1.15 million of ...
Miami Herald

IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation “CALMA” and Expands Recruitment Strategy

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
Business Wire

IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer’s Patients

POTOMAC, Md.--(BUSINESS WIRE)--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces today it has completed Cohort 3 of its Phase 1 clinical trial on IGC’s ...

IGC Pharma, Inc.: IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow

Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive analytics designed to support Alzheimer's discovery and clinical development ...

IGC Pharma, Inc.: IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company

Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts owed, including more than $552,362 of personal cash previously advanced to IGC POTOMAC, MD / ACCESS ...